Table 5.
Up-to-Date Vaccination Rates at Baseline and End of Study
| Vaccine | Baseline Up-to-date n (%) | End of Study Up-to-date n (%) | Statistical Significance |
|---|---|---|---|
| Pneumococcal | 2,456 (67.7) | 2,831 (78.1) | p < 0.001 |
| Tdap/Td | 3,940 (63.5) | 4,491 (72.3) | p < 0.001 |
| Zoster | 589 (10.6) | 1,558 (27.9) | p < 0.001 |
Tdap/Td = tetanus and diphtheria with or without pertussis; Pneumococcal includes PCV13 (pneumococcal conjugate vaccine) and PPSV23 (pneumococcal polysaccharide vaccine).